Results
133
A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.
133 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
NTES | US$87.72 | -4.8% | -18.3% | US$55.9b | US$129.05 | PE13.4x | E7.5% | 2.9% | Media | ||
CRH | US$76.09 | -11.2% | 27.9% | US$53.5b | US$97.14 | PE15.7x | E7.9% | 1.8% | Materials | ||
PCAR | US$91.64 | -7.1% | 7.3% | US$48.4b | US$110.80 | PE9.7x | E-2.3% | 4.8% | Capital Goods | ||
AMP | US$392.73 | -8.7% | 14.4% | US$38.9b | US$465.18 | PE12.6x | E3.8% | 1.5% | Diversified Financials | ||
JD | US$25.33 | -4.0% | -32.8% | US$38.9b | US$41.27 | PE11.1x | E11.2% | 3.0% | Retail | ||
VICI | US$31.48 | 0.7% | 0.4% | US$32.9b | US$35.29 | PB1.3x | E4.3% | 5.3% | Real Estate | ||
HIG | US$105.23 | -5.1% | 44.5% | US$30.8b | US$118.41 | PE10.7x | E8.2% | 1.8% | Insurance | ||
BIDU | US$82.01 | -7.4% | -42.6% | US$29.1b | US$142.16 | PE10.7x | E8.2% | n/a | Media | ||
DOV | US$172.50 | -6.4% | 20.1% | US$24.0b | US$203.32 | PE15.8x | E-10.2% | 1.2% | Capital Goods | ||
TROW | US$102.83 | -8.2% | -9.6% | US$22.9b | US$115.58 | PE12.1x | E2.3% | 4.8% | Diversified Financials | ||
KSPI | US$118.50 | -8.9% | 20.9% | US$22.5b | US$148.56 | PE11.5x | E18.3% | 6.0% | Diversified Financials | ||
WRB | US$55.98 | 1.5% | 33.8% | US$21.0b | US$59.46 | PE13.8x | E4.1% | 1.2% | Insurance | ||
ATO | US$128.10 | 0.2% | 9.0% | US$19.2b | US$129.29 | PE19.3x | E10.0% | 2.5% | Utilities | ||
SYF | US$44.30 | -12.8% | 28.8% | US$17.5b | US$55.03 | PE5.9x | E-9.2% | 2.3% | Diversified Financials | ||
FOXA | US$39.23 | 3.1% | 13.2% | US$17.5b | US$39.57 | PE12.2x | E0.8% | 1.4% | Media | ||
L | US$76.27 | -4.6% | 20.7% | US$16.8b | n/a | PE11x | n/a | 0.3% | Insurance | ||
UTHR | US$322.23 | 2.9% | 37.1% | US$14.3b | US$333.02 | PE13.4x | E6.4% | n/a | Pharmaceuticals & Biotech | ||
UHS | US$212.07 | -0.8% | 61.2% | US$14.2b | US$230.51 | PE15.2x | E9.2% | 0.4% | Healthcare | ||
RGA | US$197.58 | -12.4% | 42.8% | US$13.0b | US$239.09 | PE15.2x | E18.3% | 1.8% | Insurance | ||
EMN | US$93.82 | -9.2% | 11.2% | US$11.1b | US$113.79 | PE12.4x | E8.9% | 3.5% | Materials | ||
PR | US$13.88 | -9.5% | 12.9% | US$11.0b | US$20.78 | PE14.3x | E26.4% | 4.3% | Energy | ||
RL | US$159.39 | -9.2% | 24.0% | US$10.3b | US$190.16 | PE15.5x | E6.8% | 2.1% | Consumer Durables | ||
NVT | US$60.72 | -16.4% | 11.8% | US$10.1b | US$85.32 | PE17.5x | E-0.6% | 1.3% | Capital Goods | ||
HII | US$253.44 | -9.5% | 11.3% | US$10.1b | US$288.86 | PE13.3x | E6.1% | 2.1% | Capital Goods |